News Releases

If you are a journalist, please visit Media Source for additional information on our company and products.

Jul 14, 2010	FIRST NASAL VACCINE APPROVED IN CANADA TO PREVENT SEASONAL INFLUENZA
Jun 30, 2010	AstraZeneca and McGill partner on pain research
Mar 16, 2010	Targeted Approach Represents Paradigm Shift In The Diagnosis And Treatment Of Non-Small Cell Lung Cancer (NSCLC)
Mar 4, 2010	Astrazeneca Invests $1.2 Million In Support Of Cancer Research In British Columbia
Jan 14, 2010	HEALTH CANADA APPROVES SYMBICORT® TURBUHALER® FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE – INCREASING PATIENTS’ QUALITY OF LIFE AND REDUCING EXACERBATIONS